La Comisión Europea autoriza XOSPATA™ de Astellas para enfermos de leucemia mieloide aguda recidivante o refractaria

By In The News
October 30, 2019 in The Headlines

Recommended Posts

In The News

Posted October 30, 2019

- Share

Posted October 30, 2019

- La Comisión Europea autoriza XOSPATA™ de Astellas para enfermos de leucemia mieloide aguda recidivante o refractaria que presenten mutaciones detectadas con el análisis de mutación LeukoStrat® CDx FLT3 de Invivoscribe SAN DIEGO, 30 de octubre de 2019 /PRNewswire/ -- Invivoscribe, Inc....

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219952
2. Jaydee
  16827
3. Kip Powick
  12218
4. deicer
  12196
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.2k
- Total Posts
  
  558.9k

Sign In

La Comisión Europea autoriza XOSPATA™ de Astellas para enfermos de leucemia mieloide aguda recidivante o refractaria

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support